GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 LM/HS clade A/E CRF01 GP120 core in complex with (S)-mcg-IV-210

Analyse Crystal structure of HIV-1 LM/HS clade A/E CRF01 GP120 core in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6USW
Type
protein
Length
340 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 LM/HS clade A/E CRF01 GP120 core
UniProt
A0A0M3KKW9
Ligands
O51, NAG
Pockets
3 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 17% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 LM/HS clade A/E CRF01 GP120 coreprotein34017% helix, 38% strandA0A0M3KKW9

Ligands and binding sites

  • O51 · (3S)-N~1~-(2-aminoethyl)-N~3~-(4-chloro-3-fluorophenyl)piperidine-1,3-dicarboxamide · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.610.9118empty
2860.580.8719O51
3630.460.8317NAG

Modifications

Observed in the structure: 10 glycan, 8 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6USW · Crystal structure of HIV-1 LM/HS clade A/E CRF01 GP120 core in complex with (S)-mcg-IV-210 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.